Particle.news

Download on the App Store

Machine Learning–Powered LOCA-PRAM Enhances Point-of-Care Disease Detection

Urbana-Champaign researchers demonstrated superior biomarker detection with fewer false results, positioning the technology for clinical development.

Image

Overview

  • LOCA-PRAM creators Han Lee and Brian Cunningham integrated deep learning with photonic resonator absorption microscopy to automate molecular biomarker analysis at the point of care.
  • The team trained a physically grounded neural network by matching PRAM images of gold nanoparticle-tagged biomarkers against high-resolution scanning electron microscopy data.
  • Benchmark tests showed LOCA-PRAM detects lower biomarker concentrations and reduces both false-positive and false-negative rates compared with standard image-analysis methods.
  • Supported by the National Institutes of Health, the USDA AFRI Nanotechnology grant and the National Science Foundation, the research now moves toward clinical validation.
  • The portable assay could empower patients and non-specialists to perform rapid, high-precision diagnostics for cancer, infections and treatment monitoring outside central labs.